Drug Trial Radar · NCT06037252
A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
414
Actual
Start
Sep 21, 2023
Primary completion
Jan 8, 2026
Study completion Oct 12, 2026
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Sep 14, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes and obesity that are already taking metformin. The study will last for about 89 weeks.
Conditions
- Type 2 Diabetes
- Obesity
Interventions
TirzepatideDrug
Administered SC
PlaceboDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline in Body WeightTime frame: Baseline (Week 0), Week 44
Locations
40 sites in 4 countries. Site status is shown where the registry gives one.
Medical Advancement Centers of Arizona
Phoenix, Arizona
John Muir Physician Network Research Center
Concord, California
Care Access - Sacramento
Sacramento, California
Care Access - Aurora
Aurora, Colorado
Chase Medical Research, LLC
Waterbury, Connecticut
Retreat Medical Research
Miami, Florida
American Research Centers of Florida
Pembroke Pines, Florida
Alta Pharmaceutical Research Center
Norcross, Georgia
AGILE Clinical Research Trials, LLC
Sandy Springs, Georgia
Northwestern University
Chicago, Illinois
Qualmedica Research, LLC
Evansville, Indiana
Integrated Clinical Trial Services, Inc.
West Des Moines, Iowa
Accellacare - Wilmington - 1917 Tradd Court
Wilmington, North Carolina
Velocity Clinical Research, Mt. Auburn
Cincinnati, Ohio
Summit Headlands
Portland, Oregon
Clinical Research Associates Inc
Nashville, Tennessee
Juno Research
Houston, Texas
Southern Endocrinology Associates
Mesquite, Texas
Charlottesville Medical Research
Charlottesville, Virginia
Northwest Clinical Research Center
Bellevue, Washington
Centro de Investigaciones Metabólicas (CINME)
Buenos Aires, Argentina
CEDIC
CABA, Buenos Aires, Argentina
Consultorio de Investigación Clínica EMO SRL
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Centro Médico Viamonte
Buenos Aires, Buenos Aires F.D., Argentina
Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada
Buenos Aires, Buenos Aires F.D., Argentina
Centro de Investigacion Cardiovascular y Metabólica
Tijuana, Estado de Baja California, Mexico
Virgen Cardiovascular Research SC
Guadalajara, Jalisco, Mexico
Cryptex Investigación Clínica S.A. de C.V.
Cuauhtémoc, Ciudad de México, Mexico City, Mexico
Centro Especializado En Diabetes, Obesidad Y Prevencion De Enfermedades Cardiovasculares
Mexico City, Mexico City, Mexico
Hospital Universitario "Dr. Jose Eleuterio Gonzalez"
Monterrey, Nuevo León, Mexico
Centro de Estudios de Investigacion Metabolicos y Cardiovasculares
Ciudad Madero, Tamaulipas, Mexico
Baskent Universitesi Adana Dr. Turgut Noyan Uygulama ve Arastirma Merkezi
Adana, Turkey (Türkiye)
Akdeniz Universitesi Hastanesi
Antalya, Turkey (Türkiye)
Uludag Universitesi
Bursa, Turkey (Türkiye)
Dicle Üniversitesi
Diyarbakır, Turkey (Türkiye)
Gaziantep Universitesi Sahinbey Arastirma ve Uygulama Hastanesi
Gaziantep, Turkey (Türkiye)
Acibadem Universitesi Atakent Hastanesi
Istanbul, Turkey (Türkiye)
Marmara Universitesi Pendik Egitim Arastirma Hastanesi
Istanbul, Turkey (Türkiye)
Ondokuz Mayıs Universitesi
Samsun, Turkey (Türkiye)
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi
Kadıköy, Istanbul, Turkey (Türkiye)
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.